We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$218B
AUM Growth
-$5.41B
Cap. Flow
-$25.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
47.1%
Holding
5,603
New
345
Increased
2,379
Reduced
1,667
Closed
541

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.82B
2
AAPL icon
Apple
AAPL
+$1.62B
3
UNH icon
UnitedHealth
UNH
+$1.03B
4
XOM icon
ExxonMobil
XOM
+$869M
5
TSLA icon
Tesla
TSLA
+$701M

Sector Composition

Rank Sector Weight
1 Technology 12.19%
2 Consumer Discretionary 5.03%
3 Healthcare 4.78%
4 Financials 4.74%
5 Communication Services 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOTS
4851
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
0
BTE icon
4852
Baytex Energy
BTE
$3.04B
$4 ﹤0.01%
+1
New +$4
BYSI icon
4853
BeyondSpring
BYSI
$46.5M
$4 ﹤0.01%
4
-1,296
-100% -$2.51K
RGLS
4854
DELISTED
Regulus Therapeutics
RGLS
$4 ﹤0.01%
+5
New +$7
SOS
4855
SOS Limited
SOS
$17.3M
0
CYRN
4856
DELISTED
CYREN Ltd.
CYRN
$4 ﹤0.01%
177
BRFS
4857
DELISTED
BRF SA
BRFS
$3 ﹤0.01%
2
-56,871
-100% -$79.9K
TRVN
4858
DELISTED
Trevena, Inc.
TRVN
0
MBOT icon
4859
Microbot Medical
MBOT
$117M
$2 ﹤0.01%
1
VYNT
4860
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$2 ﹤0.01%
3
LYLT
4861
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$2 ﹤0.01%
96
-5,387
-98% -$8.96K
CRVS icon
4862
Corvus Pharmaceuticals
CRVS
$1.11B
$1 ﹤0.01%
1
MLSS icon
4863
Milestone Scientific
MLSS
$34.6M
$1 ﹤0.01%
1
SATX
4864
DELISTED
SatixFy Communications
SATX
$1 ﹤0.01%
1
AVYA
4865
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$1 ﹤0.01%
7,517
-22,758
-75% -$6.68K
AB icon
4866
AllianceBernstein
AB
$3.43B
-14
Closed -$481
ACAD icon
4867
CALL
Acadia Pharmaceuticals
ACAD
$4.55B
-50,600
Closed -$806K
ACI icon
4868
CALL
Albertsons Companies
ACI
$5.63B
-6,800
Closed -$141K
ACIC icon
4869
American Coastal Insurance
ACIC
$515M
-61,046
Closed -$64.7K
ACN icon
4870
CALL
Accenture
ACN
$99.9B
-14,800
Closed -$3.95M
ACN icon
4871
PUT
Accenture
ACN
$99.9B
-54,600
Closed -$14.6M
ADP icon
4872
PUT
Automatic Data Processing
ADP
$105B
-10,000
Closed -$2.39M
AEHR icon
4873
PUT
Aehr Test Systems
AEHR
$2.51B
-211,800
Closed -$4.26M
AEO icon
4874
CALL
American Eagle Outfitters
AEO
$2.9B
-34,500
Closed -$482K
AFRM icon
4875
CALL
Affirm
AFRM
$24.5B
-90,500
Closed -$875K

Similar funds

Barclays's Q1 2023 Portfolio in Review

As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.

  • Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
  • Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
  • Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
  • Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
  • Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
  • Barclays opened 345 new positions and closed 541 in Q1 2023.
  • Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.